Literature DB >> 27773474

Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.

Mariam Dvalishvili1, Darejan Mesxishvili2, Maia Butsashvili3, George Kamkamidze4, Deborah McFarland5, Robert A Bednarczyk6.   

Abstract

OBJECTIVE: To document knowledge, attitudes, and practices of Georgian obstetrician-gynecologists concerning influenza infection and vaccination during pregnancy.
METHODS: We conducted a cross-sectional study of obstetrician-gynecologists in 8 cities in the country of Georgian, from June to July, 2015, using an anonymous, self-administered, written survey. Collected data included demographics; knowledge, attitudes, and practices related to influenza vaccination during pregnancy; perceptions of influenza infection in pregnancy; perceived barriers to influenza vaccination during pregnancy; and willingness to receive education about influenza infection and vaccination during pregnancy.
RESULTS: A total of 278 obstetrician-gynecologists completed surveys. Most physicians perceived influenza to be a serious infectious disease (88%) and that pregnant women are more susceptible to it than the general population. Only 43% of physicians reported recommending influenza vaccination during pregnancy; 18% reported vaccinating any pregnant patients during the last influenza season. Most (75%) physicians reported a perception that there is insufficient evidence supporting influenza vaccination during pregnancy. Most (93%) were receptive to receiving additional education on maternal vaccination.
CONCLUSIONS: Georgian physicians are hesitant to vaccinate pregnant women, but are receptive to education about maternal vaccination. Future educational outreach to Georgian physicians could reduce concerns about maternal vaccination, potentially increasing influenza vaccination among pregnant Georgian women.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health knowledge and beliefs; Influenza; Pregnancy; Recommendations; Vaccination

Mesh:

Substances:

Year:  2016        PMID: 27773474     DOI: 10.1016/j.vaccine.2016.10.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Trends of influenza vaccination coverage in pregnant women: a ten-year analysis from a French healthcare database.

Authors:  Mélodie Corbeau; Aurélien Mulliez; Chouki Chenaf; Bénédicte Eschalier; Olivier Lesens; Philippe Vorilhon
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

2.  Antenatal influenza vaccination in urban Pune, India: clinician and community stakeholders' awareness, priorities, and practices.

Authors:  Joseph G Giduthuri; Vidula Purohit; Abhay Kudale; Jürg Utzinger; Christian Schindler; Mitchell G Weiss
Journal:  Hum Vaccin Immunother       Date:  2020-09-23       Impact factor: 3.452

Review 3.  Barriers and Facilitators Associated With Vaccine Acceptance and Uptake Among Pregnant Women in High Income Countries: A Mini-Review.

Authors:  Xiao Qiu; Heather Bailey; Claire Thorne
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 4.  The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy.

Authors:  Kathleen F Morales; Lisa Menning; Philipp Lambach
Journal:  Vaccine       Date:  2020-06-02       Impact factor: 3.641

5.  Severe Acute Respiratory Infection (SARI) sentinel surveillance in the country of Georgia, 2015-2017.

Authors:  Giorgi Chakhunashvili; Abram L Wagner; Laura E Power; Cara B Janusz; Ann Machablishvili; Irakli Karseladze; Olgha Tarkhan-Mouravi; Khatuna Zakhashvili; Paata Imnadze; Gregory C Gray; Benjamin Anderson; Matthew L Boulton
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

6.  Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador.

Authors:  Carlos E Erazo; Carlos V Erazo; Mario J Grijalva; Ana L Moncayo
Journal:  BMC Public Health       Date:  2021-01-07       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.